← Leaderboards
Todd H. Rider
Harvard Medical School
$1,036,647
Attributed
$1,036,647
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $630.9K · FY2012–13$1M$750K$500K$250K$0
'12
'13
Funding mix
By agency
NIH$1,036,647 · 3
By mechanism
U54$578,660 · 2
R56$457,987 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Ulrich H Von Andrian$44,950,919
- Jesse Dylan Pyle$101,548
- Carl Alexander Moon-Walker$53,510
- Jaclyn Kline$80,685
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusDisadvantagedProphylacticViralCategoriesDouble-Stranded RnaKillingsPathogenCaspaseSuccessVirus DiseasesCellsProtocols DocumentationApoptosisAntiviral AgentsAdverse EffectsBiodefenseNational Institute Of Allergy And Infectious DiseaseCell TypeArenavirusInstructionAnimal ModelInfluenza A Virus, H1n1 SubtypeInterest
Grant awards (4)
Developing High-Throughput Assays for DRACO Broad-Spectrum Antiviral Molecules$448,949
R56 · FY2013 · AI · contact PI
PANACEA Broad-spectrum Antiviral Therapeutics$172,903
U54 · FY2013 · AI · contact PI
Developing High-Throughput Assays for DRACO Broad-Spectrum Antiviral Molecules$9,038
R56 · FY2013 · AI · contact PI
PANACEA Broad-spectrum Antiviral Therapeutics$405,757
U54 · FY2012 · AI · contact PI